Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Norris Medicines Ltd has submitted a routine quarterly compliance certificate to BSE, confirming that share certificates received for dematerialisation between 1 October 2025 and 31 December 2025 were processed by its Registrar and Transfer Agent, Purva Sharegistry (India) Pvt Ltd. The certificate confirms that physical shares were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's records within the prescribed timelines. The attached list shows 24 individual shareholders converting a total of around 1,260 physical shares into demat form during the quarter. This is a standard regulatory filing required under SEBI's depository rules and contains no new business or financial information.
No material impact on shareholders or the stock price — this is a routine administrative filing confirming that normal dematerialisation activity was completed correctly during the quarter.